CBD trial aims to reduce stress, anxiety and depression in children and teens with autism spectrum disorder (ASD). We are currently enrolling children and adolescents between 6-17 years old who have a diagnosis of ASD to participate in a clinical trial designed to improve social communication, and reduce stress, anxiety and depression in children and teens with autism. In this study, participants will attend a 12-week intervention using flavored cannabidiol, or CBD, oral solution
STUDY SNAPSHOT • Parents/caregivers will administer a flavored oral solution of CBD. • Most in-person visits can be substituted with a video session and visit from an in-home nurse. • All study-related care, tests and study procedures with be provided to participants at no cost. • Participants can earn up to $300 by completing all 10 study visits. • Note: CBD does not contain THC (the compound responsible for the euphoric sensation associated with marijuana) Study Participation Will Involve • (3) in-person visits at SARRC 16th St. Campus following strict COVID safety policies. • (3) visits have the option to be in-person at SARRC or at home using video chat and a visit from an in-home nurse. • (4) phone call visits lasting 5-10 minutes. • Participation will include blood draws at three visits. WHO WE ARE SARRC’s research program brings together scientists, research methods, and stakeholders to gain a better understanding of possible causes of autism, identify better treatments, and educate others about how to improve the quality of life for those impacted by ASD and their families.
For more information: